Start free trial
Markets United Kingdom Stocks Finance Financial Conglomerates

OKYO PHARMA LIMITED ORD NPV
OKYO LSE

OKYO
OKYO PHARMA LIMITED ORD NPV LSE
Trade now
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Trade now
Overview
Ideas Financials Technicals

OKYO Stock Chart

Ideas

Videos only

No ideas here yet

Add idea

Be the first!

Add idea

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Finance
Industry: Financial Conglomerates
OKYO Pharma Ltd. is a biopharmaceutical company, which engages in developing therapeutics for inflammatory eye diseases and chronic pain. It focuses on the Chemerin project. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.

News